SCHEMBL1831785

SCHEMBL1831785

CCC(=O)N(C)CCCNC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
PRMT3 O60678 1/20 0.36
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
PRMT1 Q99873 1/20 0.36
PRMT8 Q9NR22 1/20 0.36
EPHX1 P07099 1/20 0.34
DNM1 Q05193 2/20 0.33
EPHX2 P34913 2/20 0.33
CNR1 P21554 1/20 0.33
S1PR2 O95136 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
S1PR5 Q9H228 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PAOX Q6QHF9 1/20 0.32
KISS1R Q969F8 1/20 0.32
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16384280 0.92 KDM4A (0.45) KDM4AKDM4CPRMT3CARM1PRMT6
SCHEMBL1831524 0.87 PRMT3 (0.44) KDM4AKDM4CPRMT3CARM1PRMT6
SCHEMBL14048616 0.84 KDM4C (0.41) KDM4AKDM4CEPHX1DNM1EPHX2
SCHEMBL27317414 0.83 KDM4A (0.43) KDM4AKDM4CPRMT3CARM1PRMT6
SCHEMBL1833856 0.82 CYP2C19 (0.41) DNM1MEN1KMT2APAOXALDH1A1
SCHEMBL8633748 0.80 CNR1 (0.39) EPHX2CNR1MEN1KMT2AALDH1A1
SCHEMBL8746083 0.80 EPHX2 (0.55) KDM4AKDM4CEPHX1DNM1EPHX2
SCHEMBL19316250 0.79 KDM4C (0.44) KDM4AKDM4CEPHX1DNM1EPHX2
SCHEMBL19757980 0.79 KISS1R (0.40) KDM4AKDM4CPRMT3CARM1PRMT6
SCHEMBL3713274 0.78 KDM4A (0.42) KDM4AKDM4CPRMT3CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3929185-A1 NITROGEN-CONTAINING FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2021-12-29 EP disclosed
EP-2323145-A1 Electrolytic solution for electrolytic capacitor and electrolytic capacitor as well as method for preparing an organic onium tetrafluoroaluminate MITSUBISHI CHEMICAL CORPORATION (JP) 2011-05-18 EP disclosed
EP-2323144-A1 Electrolytic capacitor MITSUBISHI CHEMICAL CORPORATION (JP) 2011-05-18 EP disclosed
US-7397651-B2 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2008-07-08 US disclosed
US-7295424-B2 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2007-11-13 US disclosed
US-20070188977-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM MITSUBISHI CHEMICAL CORPORATION (JP) 2007-08-16 US disclosed
US-20070188979-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM MITSUBISHI CHEMICAL CORPORATION (JP) 2007-08-16 US disclosed
US-7227738-B2 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2007-06-05 US disclosed
US-20060007629-A1 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2006-01-12 US disclosed
EP-1564768-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM Mitsubishi Chemical Corporation (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070188977-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM AFF2, CACNA2D2, AFF4 KDM4A 2237/4885KDM4C 1441/4885PRMT3 2483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.